A detailed history of Continuum Advisory, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 8,671 shares of MRK stock, worth $844,902. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,671
Previous 8,372 3.57%
Holding current value
$844,902
Previous $1.04 Million 5.02%
% of portfolio
0.13%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $33,233 - $38,562
299 Added 3.57%
8,671 $984,000
Q2 2024

Jul 19, 2024

SELL
$123.8 - $132.96 $1,114 - $1,196
-9 Reduced 0.11%
8,372 $1.04 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $318,883 - $371,571
-2,816 Reduced 25.15%
8,381 $1.11 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $199,258 - $216,840
-1,989 Reduced 15.08%
11,197 $1.22 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $167,293 - $185,786
-1,625 Reduced 10.97%
13,186 $1.36 Million
Q2 2023

Dec 13, 2023

SELL
$108.61 - $118.38 $1.84 Million - $2 Million
-16,924 Reduced 53.33%
14,811 $1.71 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $1.84 Million - $2 Million
-16,924 Reduced 53.33%
14,811 $1.71 Million
Q1 2023

Dec 13, 2023

SELL
$102.94 - $114.86 $9,264 - $10,337
-90 Reduced 0.28%
31,735 $3.38 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $9,264 - $10,337
-90 Reduced 0.28%
31,735 $3.38 Million
Q4 2022

Dec 13, 2023

SELL
$87.44 - $112.11 $103,616 - $132,850
-1,185 Reduced 3.59%
31,825 $3.53 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $103,616 - $132,850
-1,185 Reduced 3.59%
31,825 $3.53 Million
Q3 2022

Dec 13, 2023

BUY
$84.53 - $94.96 $260,859 - $293,046
3,086 Added 10.31%
33,010 $2.84 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $260,859 - $293,046
3,086 Added 10.31%
33,010 $2.84 Million
Q2 2022

Dec 13, 2023

BUY
$83.49 - $94.64 $459,445 - $520,803
5,503 Added 22.53%
29,924 $2.73 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $459,445 - $520,803
5,503 Added 22.53%
29,924 $2.73 Million
Q1 2022

Dec 13, 2023

BUY
$73.51 - $82.4 $1.19 Million - $1.33 Million
16,158 Added 195.55%
24,421 $2 Million
Q1 2022

May 17, 2022

BUY
$73.51 - $82.4 $1.19 Million - $1.33 Million
16,158 Added 195.55%
24,421 $2.17 Million
Q4 2021

Dec 13, 2023

BUY
$72.28 - $90.54 $119,984 - $150,296
1,660 Added 25.14%
8,263 $633,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $119,984 - $150,296
1,660 Added 25.14%
8,263 $633,000
Q3 2021

Dec 13, 2023

BUY
$71.68 - $78.83 $38,778 - $42,647
541 Added 8.92%
6,603 $495,000
Q3 2021

Nov 08, 2021

BUY
$71.68 - $78.83 $38,778 - $42,647
541 Added 8.92%
6,603 $496,000
Q2 2021

Dec 13, 2023

SELL
$70.31 - $77.77 $500,888 - $554,033
-7,124 Reduced 54.03%
6,062 $471,000
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $426,219 - $471,441
6,062 New
6,062 $471,000
Q1 2018

May 18, 2021

SELL
$50.96 - $59.23 $238,951 - $277,729
-4,689 Closed
0 $0
Q4 2017

May 18, 2021

BUY
$51.62 - $61.64 $37,837 - $45,182
733 Added 18.53%
4,689 $264,000
Q3 2017

May 18, 2021

BUY
$58.67 - $63.13 $24,054 - $25,883
410 Added 11.56%
3,956 $253,000
Q2 2017

May 18, 2021

BUY
N/A
3,546
3,546 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.